John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cisco
CSCO
|
+$226M |
| 2 |
JPMorgan Chase
JPM
|
+$212M |
| 3 |
TSMC
TSM
|
+$204M |
| 4 |
Occidental Petroleum
OXY
|
+$194M |
| 5 |
Apple
AAPL
|
+$180M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$271M |
| 2 |
Microsoft
MSFT
|
+$267M |
| 3 |
Canadian Pacific Kansas City
CP
|
+$255M |
| 4 |
Thermo Fisher Scientific
TMO
|
+$226M |
| 5 |
Coca-Cola
KO
|
+$225M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.48% |
| 2 | Healthcare | 15.21% |
| 3 | Industrials | 10.23% |
| 4 | Consumer Discretionary | 10.15% |
| 5 | Financials | 9.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NARI
1026
DELISTED
Inari Medical, Inc. Common Stock
NARI
| $3.85M | 0.01% |
+42,508
| New | +$3.48M |
|
1027
SITE Centers
SITC
$161M
| $3.85M | 0.01% |
+295,449
| New | +$3.6M |
|
|
INN
1028
Summit Hotel Properties
INN
$662M
| $3.84M | 0.01% |
385,511
+170,486
| +79% | +$1.68M |
|
1029
PUT
PG&E
PCG
$39.9B
| $3.84M | 0.01% |
321,300
+299,500
| +1,374% | +$3.54M |
|
1030
OceanFirst Financial
OCFC
$1.83B
| $3.83M | 0.01% |
190,480
+219
| +0.1% | +$4.88K |
|
|
PGRE
1031
DELISTED
Paramount Group
PGRE
| $3.83M | 0.01% |
350,987
+39,992
| +13% | +$390K |
|
1032
Ericsson
ERIC
$33.3B
| $3.83M | 0.01% |
+418,808
| New | +$4.36M |
|
1033
EastGroup Properties
EGP
$10.9B
| $3.82M | 0.01% |
+18,784
| New | +$3.72M |
|
|
AVID
1034
DELISTED
Avid Technology Inc
AVID
| $3.82M | 0.01% |
109,434
-118,500
| -52% | -$3.68M |
|
1035
Valaris
VAL
$5.96B
| $3.81M | 0.01% |
+73,350
| New | +$3.18M |
|
|
HEES
1036
DELISTED
H&E Equipment Services
HEES
| $3.8M | 0.01% |
87,220
+17,299
| +25% | +$727K |
|
1037
Ryder
R
$9.39B
| $3.79M | 0.01% |
+47,774
| New | +$3.72M |
|
1038
Signet Jewelers
SIG
$3.24B
| $3.79M | 0.01% |
+52,071
| New | +$4.16M |
|
1039
Radware
RDWR
$1.16B
| $3.77M | 0.01% |
118,060
-42,117
| -26% | -$1.4M |
|
|
AZUL
1040
DELISTED
Azul
AZUL
| $3.76M | 0.01% |
+250,037
| New | +$3.59M |
|
|
MODN
1041
DELISTED
MODEL N, INC.
MODN
| $3.76M | 0.01% |
139,893
-82,836
| -37% | -$2.16M |
|
1042
CVR Energy
CVI
$3.82B
| $3.76M | 0.01% |
147,310
+62,214
| +73% | +$1.29M |
|
1043
Algoma Steel
ASTL
$424M
| $3.75M | 0.01% |
+333,702
| New | +$3.29M |
|
1044
EXL Service
EXLS
$5.71B
| $3.74M | 0.01% |
130,520
+51,125
| +64% | +$1.3M |
|
|
AXAC
1045
DELISTED
AXIOS Sustainable Growth Acquisition Corporation
AXAC
| $3.74M | 0.01% |
+375,000
| New | +$3.74M |
|
1046
Viking Therapeutics
VKTX
$3.88B
| $3.73M | 0.01% |
1,244,092
+310,611
| +33% | +$1.11M |
|
1047
AppFolio
APPF
$7.97B
| $3.72M | 0.01% |
+32,841
| New | +$3.78M |
|
1048
Conduent
CNDT
$250M
| $3.72M | 0.01% |
+720,508
| New | +$3.54M |
|
|
ITAQ
1049
DELISTED
Industrial Tech Acquisitions II, Inc. Class A Common Stock
ITAQ
| $3.72M | 0.01% |
+375,000
| New | +$3.72M |
|
1050
Replimune Group
REPL
$1.39B
| $3.71M | 0.01% |
218,792
+122,084
| +126% | +$2.3M |
|
Similar funds
John Overdeck's Q1 2022 Portfolio in Review
As of Q1 2022, John Overdeck held 4,846 positions worth $33.9B, down 28% from $46.8B the previous quarter. Its ten largest holdings account for 7.2% of the portfolio.
John Overdeck withdrew a net $11.3B in Q1 2022, closing 2,304 positions and reducing 976 holdings. Its most notable exit was Pfizer, an estimated $271M position sold in full.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, John Overdeck opened a new position in Cisco worth $223M.
- John Overdeck's largest Q1 2022 buy was Cisco: 4,001,362 shares worth $223M.
- John Overdeck added most to JPMorgan Chase in Q1 2022, an estimated $212M increase.
- John Overdeck's biggest Q1 2022 reduction was Coca-Cola, cutting an estimated $225M.
- John Overdeck fully exited Pfizer in Q1 2022, selling an estimated $271M.
- John Overdeck's ten largest holdings make up 7.2% of its $33.9B portfolio in Q1 2022.
- John Overdeck opened 656 new positions and closed 2,304 in Q1 2022.
- John Overdeck's portfolio value fell 28% quarter-over-quarter to $33.9B.
Based on Two Sigma Investments's 13F filing for Q1 2022, filed 16 May 2022.